• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Authors » Aaron Lorenzo

Articles by Aaron Lorenzo

Genzyme Regains Synvisc Rights From Wyeth For $121M Up Front

Nov. 5, 2004
By Aaron Lorenzo
The Cambridge, Mass.-based company entered an agreement with Wyeth Pharmaceuticals to buy back rights for the osteoarthritis product in the U.S. and five European countries. As a result, Genzyme will receive all end-user revenue in those territories for Synvisc (hylan G-F 20), the top-selling viscosupplementation product for pain due to osteoarthritis of the knee in the U.S. and Canada. (BioWorld Today)
Read More

California Voters Back Prop. 71 For $3B In Stem Cell Research

Nov. 4, 2004
By Aaron Lorenzo
California stem cell researchers might get a boost through the passage of Proposition 71, paving the way for $3 billion in state-backed funding, and biotech companies hope to feel some trickle-down effect. (BioWorld Today)
Read More

California Voters Back Prop. 71 For $3B In Stem Cell Research

Nov. 4, 2004
By Aaron Lorenzo
California stem cell researchers might get a boost through the passage of Proposition 71, paving the way for $3 billion in state-backed funding, and biotech companies hope to feel some trickle-down effect. (BioWorld Today)
Read More

Genaera Generates $13M Through Direct Stock Sale

Nov. 3, 2004
By Aaron Lorenzo

Genaera Generates $13M Through Direct Stock Sale

Nov. 3, 2004
By Aaron Lorenzo

Nastech Gets Approvable Letter For Nascobal Spray

Nov. 2, 2004
By Aaron Lorenzo
Nastech Pharmaceutical Co. Inc.'s reformulated treatment for vitamin B-12 deficiency, Nascobal (cyanocobalamin) Nasal Spray, received an approvable letter from the FDA. (BioWorld Today)
Read More

Nastech Gets Approvable Letter For Nascobal Spray

Nov. 2, 2004
By Aaron Lorenzo
Nastech Pharmaceutical Co. Inc.'s reformulated treatment for vitamin B-12 deficiency, Nascobal (cyanocobalamin) Nasal Spray, received an approvable letter from the FDA. (BioWorld Today)
Read More

Xcyte Raises $26M Through Placement Of Preferred Stock

Nov. 1, 2004
By Aaron Lorenzo

Xcyte Raises $26M Through Placement Of Preferred Stock

Nov. 1, 2004
By Aaron Lorenzo

Three-Year Data Suggest Broader Provenge Label In Prostate Cancer

Oct. 29, 2004
By Aaron Lorenzo
Boosting hopes for a wider label than previously thought, Dendreon Corp. released final three-year follow-up data from a Phase III study of Provenge. (BioWorld Today)
Read More
Previous 1 2 … 122 123 124 125 126 127 128 129 130 … 237 238 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 25, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 25, 2025.
  • Brain and neural networks

    Proteomics finds surprise commonalities as well as differences in neurodegenerative diseases

    BioWorld
    The switch will be flicked today to make the world’s largest dementia-related proteomics dataset freely available to researchers, at the same time as members of...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 22, 2025
  • Pfizer describes new STAT6 inhibitors

    BioWorld Science
    Pfizer Inc. has identified signal transducer and activator of transcription 6 (STAT6) inhibitors reported to be useful for the treatment of Alzheimer’s disease,...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe